mefloquine has been researched along with African Sleeping Sickness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agnamey, P; Azas, N; Cohen, A; Daulouede, S; Del Favero, M; Farvacques, N; Guillon, J; Hutter, S; Le Pape, P; Mullié, C; Pagniez, F; Pinaud, N; Ronga, L; Savrimoutou, S; Sonnet, P; Soum, C; Vincendeau, P | 1 |
Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V | 1 |
Onabanjo, AO; Otigbuo, IN | 1 |
3 other study(ies) available for mefloquine and African Sleeping Sickness
Article | Year |
---|---|
Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Topics: Animals; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Female; Hep G2 Cells; Humans; Leishmania; Macrophages; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2014 |
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2015 |
The in vitro and in vivo effects of mefloquine on Trypanosoma brucei brucei.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Drug Administration Schedule; Kidney; Male; Mefloquine; Mice; Trypanosoma brucei brucei; Trypanosomiasis, African | 1992 |